Právní předpis byl sestaven k datu 17.01.2025.
Zobrazené znění právního předpisu je účinné od 17.01.2025 do 15.12.2025.
§1
Předmět xxxxxx
Xxxx xxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxx, xxxxx xx xxxxxx x příloze k tomuto xxxxxxxx.
§2
Oznámení xxxxxxxxxxx xxxxxxxx
Xxxx xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Evropského xxxxxxxxxx x Xxxx (XX) 2015/1535 xx dne 9. září 2015 x xxxxxxx při xxxxxxxxxxx informací v xxxxxxx xxxxx a xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro xxxxxx xxxxxxxxxx xxxxxxxxxxx.
§3
Účinnost
Toto nařízení xxxxxx xxxxxxxxx dnem xxxxxxxxxxxx xx xxx xxxx xxxxxxxxx.
&xxxx;
Xxxxxxxx xxxxx:
xxxx. PhDr. Xxxxx, Xx.X., XX.X., x. x.
&xxxx;
Xxxxxxxxxxxxx xxxxx x xxxxxxx xxxxxxxxxxxxx:
xxxx. XXXx. Xxxxx, XXx., XXX, XXXX, x. x.
Příloha
Seznam zařazených xxxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxx |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxx |
XXXX |
6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxx |
XXXX; XXX-X6 |
6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(6xX,10xX)-6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
X xxxxxxxx xxxxx XXX, xxxxx je xxxxxxxx v xxxxxxxx xxxxxxxxxxx xxxxxx, xxxxxxxxxx xxxxxx, xxxxxx xxxxxxx x tinktura x xxxxxxxxx z xxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxx xxx 0,3 %. Tato xxxxxxx xx xxxxxxxxxx na xxxxxxxxx. |
|
|
Xxxxxxxxxxxxxxxxxxxx |
XXX-X8 |
6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxx |
XXXX; XXX-X4 |
6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(6xX,10xX)-3-xxxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
X xxxxxxxx xxxxx XXXX, xxxxx je xxxxxxxx x xxxxxxxx xxxxxxxxxxx xxxxxx, technickém xxxxxx, xxxxxx xxxxxxx x xxxxxxxx a xxxxxxxxx x xxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxx než 0,3 %. Xxxx xxxxxxx xx nevztahuje xx xxxxxxxxx. |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXXX; THC-H6 |
(6aR,10aR)-3-hexyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol |
Včetně xxxxx-8 xxxxxxx. |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX-X8 |
(6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
Xxxxxx xxxxx-8 xxxxxxx. |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX; XXX-X4 |
(6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
Xxxxxx xxxxx-8 xxxxxxx. |
|
|
5-Xxxxxxxxxxxxxxxxxx |
1-(5-xxxxxxxxxxxxx-2-xx)xxxxxx-2-xxxx |
|||
|
XXX-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
|
X-XXXXX-XXXX |
3-(2X-1,3-xxxxxxxxxxx-5-xx)-2-xxxxxxx-X,2-xxxxxxxx-3-(xxxxxxxxxxx)xxxxxxxxxx |
|||
|
Xxxxxxxx |
X-xxxxxx-1-(5-xxxxxx-2-xxxxxxx)xxxxxx-2-xxxx |
|||
|
2-Xxxxx-xxxxxxxx-X-xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(2-xxxxxxxxxx)xxxxxxxxxxxx |
|||
|
3-Xx-XXX |
1-[1-(3-xxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|||
|
3X-XXX |
1-[1-(3-xxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|||
|
3-Xx-XXX |
1-[1-(3-xxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|||
|
3-Xx-XXXx |
1-[1-(3-xxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxx)-xxxxxxxxxxxx |
|||
|
Xxxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxx)xxxxxxxxxx-1-xx |
|||
|
Xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)-xxxxxxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|||
|
4'-Xxxxxxxxxxxxxxxxxxxxxxx |
6-(4-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
|||
|
Xxxxxxxxxx |
1,1-xxxxxxxxxxxxx 8-xxxx-11,12,13,13x-xxxxxxxxxx-9-xxx-9X-xxxxxxx[1,5-x]xxxxxxx[2,1-x][1,4]xxxxxxxxxxxxx-1-xxxxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
7-xxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|||
|
Xxxxxxxxxxxxxxxxxx |
2-xxxxx-9-xxxxxx-4-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|||
|
Xxxxxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx [4,3-x][1,4]xxxxxxxx |
|||
|
Xxxxxxxxxxx |
2-xxxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx |
|||
|
6-XX-XXXXX |
2-xxxx-4,5-xxxxxxxxxxxxxxxxxxxxx |
|||
|
X-xxxxxxxxxxxx-3,4-XXX |
1-[2-(3,4-xxxxxxxxxxxxxx)-1-xxxxxxxxxxx]-xxxxxxxxxx |
|||
|
XXXX |
X-xxxxx-1-xxxxxxxxxxx-2-xxxx |
|||
|
2-(4-Xxxxxxxxxxxxxxx-1-xx)-1-xxxxx xxxxxx-1-xx |
2-(4-xxxxxxxxxxxxxxx-1-xx)-1-xxxxxxxxxxx-1-xx |
|||
|
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxx-1-xx |
|||
|
2'-Xx-XXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
|
2-Xxxxxx-α-XXxX |
4-xxxxxx-1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx) xxxxxx-1-xx |
|||
|
3,4-Xx-XxxXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxx-1-xx) xxxxxx-1-xx |
|||
|
3X-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxx)xxxxx-1-xx |
|||
|
3X-X-xxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxx)xxxxx-1-xx |
|||
|
3X-α-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
|
3-Xxxxxxxxxxxxx |
2-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|||
|
3'-Xx-XXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
|
3-Xxxxxx-X-xxxxxx-xxxxxxxx |
2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)-1-xxxxxxxx |
|||
|
4’-Xxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)-1-xxxxxxx |
|||
|
4-Xx-3-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|||
|
4X-3-xxxxxx-α-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxx-1-xx |
|||
|
4X-3-xxxxxx-α-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
|
XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
|
XXXXxX |
1-(1,3-xxxxxxxxxxx-5-xx)-4-xxxxxx-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|||
|
X,X-xxxxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxx)xxxxxx-1-xx |
|||
|
X-xxxxxxxxxxxx |
1-(2X-1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|||
|
X-xxxxxxxxxx butylon |
1-(1,3-benzodioxol-5-yl)-2-(cyklohexylamino)butan-1-on |
|||
|
N-cyklohexyl xxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxxxx)xxxxxx-1-xx |
|||
|
X-xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|||
|
X-xxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|||
|
X-xxx-xxxxx-xxxxxxxxx |
2-[(xxxxx-2-xx)xxxxx]-1-xxxxxxxxxxx-1-xx |
|||
|
α-X2XX |
1,2-xxxxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
|
α-XXXX |
2-xxxxxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
|
3-Xxxxxxxxxxxxxxxx |
2-(3-xxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|||
|
3-Xxxxxxxxxxxxxxxxxx |
2-(3-xxxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|||
|
4Xx-XXX |
5-(4-xxxxxxxxx)-4-xxxxxx-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
|||
|
4Xx-XXX |
5-(4-xxxxxxxxxx)-4-xxxxxx-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
|||
|
4-Xxxxxxxxxxxx |
4-xxxxx-3-(4-xxxxxxxxxx)xxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
5-xxxxx-3-(4-xxxxx-2-xxxxxxxxxxx)-2-xxxxxx-4(3X)-xxxxxxxxxxxx |
|||
|
Xxxxxxxxx |
2-xxxxx-3-xxxxxxxxxxxxxxx-4(3X)-xx |
|||
|
Xxxxxxxxx |
2-(xxxxxxxxxx)-5-xxxxx-4(5X)-xxxxxxxx |
|||
|
Xxx-(xxxx-xxxxxx-xxxxxxxxxxxx) |
1-(3-xxxxxxxxxxx)-1-(xxxxxxxxxxx)xxxxxx-2-xx |
|||
|
Xxx-3-XXX |
1-(3-xxxxxxxxxx)-1-(xxxxxxxxxxx)xxxxxx-2-xx |
|||
|
Xxx-3-XXX |
1-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-2-xx |
|||
|
X-xxxxx zolpidem |
N-ethyl-2-[6-methyl-2-(4-methylfenyl)imidazo[1,2-a]pyridin-3-yl]acetamid |
|||
|
Nitrometakvalon |
3-(2-methoxy-4-nitrofenyl)-2-methylchinazolin-4-on |
|||
|
Pagoklon |
2-(7-chlor-1,8-naftyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-1H-isoindol-1-on |
|||
|
Rilmazafon |
5-[[(2-aminoacetyl)amino]methyl]-1-[4-chlor-2-(2-chlorbenzoyl)fenyl]-N,N-dimethyl-1H-1,2,4-triazol-3-karboxamid |
|||
|
3,4-CFP |
1-(3-chlor-4-fluorfenyl)piperazin |
|||
|
4F-MBZP |
1-[(4-fluorfenyl)methyl]-4-methylpiperazin |
|||
|
pBPP |
1-(4-bromfenyl)piperazin |
|||
|
4,4-Dimethyl-1-fenyl-1-pyrrolidin-1-yl-pentan-3-on |
4,4-dimethyl-1-fenyl-1-pyrrolidin-1-yl-pentan-3-on |
|||
|
Methyl 2-xxxxx-2-(xxxxxxxxxx-1-xx) xxxxxx |
xxxxxx 2-fenyl-2-(pyrrolidin-1-yl)acetát |
|||
|
3,5-ADB-4en-PFUPPYCA |
N-(1-karbamoyl-2,2-dimethyl-propyl)-5-(4-fluorfenyl)-2-pent-4-enyl-pyrazol-3-karboxamid |
|||
|
4en-PDMB-4en-PINACA |
pent-4-en-1-yl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido)-butanoát |
|||
|
4F-ABINACA |
N-(adamantan-1-yl)-1-(4-fluorbutyl)-1H-indazol-3-karboxamid |
|||
|
5,3-AB-CHMFUPPYCA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-5-(4-fluorfenyl)-1H-pyrazol-3-karboxamid |
|||
|
5,3-ADB-4en-PFUPPYCA |
N-(1-karbamoyl-2,2-dimethyl-propyl)-5-(4-fluorfenyl)-1-pent-4-enyl-pyrazol-3-karboxamid |
|||
|
5B-AKB48 |
N-(1-adamantyl)-1-(5-brompentyl)indazol-3-karboxamid |
|||
|
5F-BZO-POXIZID |
N-[(Z)-[1-(5-fluorpentyl)-2-oxo-indolin-3-yliden]amino] xxxxxxxx |
|||
|
5X-XXXX-XXXX |
xxxxx 2-(1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
|
5X-XXX-XXXX |
xxxxx 2-[[1-(5-fluorpentyl)indol-3-karbonyl]amino]-3-methyl-butanoát |
|||
|
ABO-4en-PINACA |
N-(1-amino-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid |
|||
|
ADB-4en-P-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid |
|||
|
ADB-4en-PINACA |
N-(1-amino-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid |
|||
|
ADB-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1H-indazol-3-karboxamid |
|||
|
ADB-B-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-butyl-1H-indazol-3-karboxamid |
|||
|
ADB-BUTINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazol-3-karboxamid |
|||
|
ADB-D-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-decyl-1H-indazol-3-karboxamid |
|||
|
ADB-FUBHQUCA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorfenyl)methyl-1,4-dihydrochinolin-3-karboxamid |
|||
|
ADB-FUBIACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indol-3-acetamid |
|||
|
ADB-HEXINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazol-3-karboxamid |
|||
|
ADB-IACA |
2-[2-(1H-indol-3-yl)acetamido]-3,3-dimethylbutanamid |
|||
|
ADB-P-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-pentyl-1H-indazol-3-karboxamid |
|||
|
ADMB-3TMS-PRINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazol-3-karboxamid |
|||
|
ADMB-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazol-3-karboxamid |
|||
|
A-FUBIACA |
N-(1-adamantyl)-2-[1-[(4-fluorfenyl)methyl]indol-3-yl]acetamid |
|||
|
A-PBITMO |
(adamantan-1-yl)(3-pentyl-2-thioxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methanon |
|||
|
A-PONASA |
N-adamantyl-4-(pentyloxy)naftalen-1-sulfonamid |
|||
|
BENZYL-4CN-BINACA |
N-benzyl-1-(4-kyanobutyl)-1H-indazol-3-karboxamid |
|||
|
BZO-4en-POXIZID |
N-[(Z)-(2-oxo-1-pent-4-enyl-indolin-3-yliden)amino]benzamid |
|||
|
BZO-POXIZID |
N-[(Z)-(2-oxo-1-pentyl-indolin-3-yliden)amino]benzamid |
|||
|
CUMYL-1Cl-CHSINACA |
1-(1-chlorcyklohexyl)sulfonyl-N-(1-methyl-1-fenyl-ethyl)indazol-3-karboxamid |
|||
|
CUMYL-3TMS-PRINACA |
N-(2-fenylpropan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazol-3-karboxamid |
|||
|
Cumyl-BC-HpMeGaClone-221 |
(5-(bicyklo[2.2.1]hept-2-yl)methyl)-2-(2-fenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-on |
|||
|
Cumyl-CB-MeGaClone |
5-(cyklobutylmethyl)-2-(1-methyl-1-fenyl-ethyl)pyrido [4,3-x]xxxxx-1-xx |
|||
|
XXXXX-XXXXXX |
1-(xxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXXXXX |
1-(xxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXXXXX |
1-(xxxxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXXX |
1-(xxxxxxx[2.2.1]xxxxxx-2-xxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XXXXXXXX |
(1-(xxxxxxx[2.2.1]xxxxxx-2-xx)xxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXXX-XxXXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
|
XXXX-XXXXXX |
xxxxx 3,3-xxxxxxxx-2-[(1-xxxxxxxxxxxxx-3- xxxxxxxx)xxxxx] xxxxxxxx |
|||
|
XXXXXX |
1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxx-3-xxxxxx |
|||
|
XX-XXXXXXXXXX |
X-{5-xxxx-1-[(4-xxxxxxxxxx)xxxxxx]-4-xxxxxx-2-xxx-1,2-xxxxxxxxxxxxxx-3-xx}xxxxxxxxxxxxxxxxxxxx |
|||
|
XX-XXXXXXX |
X-xxxxxxxxxx-2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xx)xxxxxxxx |
|||
|
XX-XXXX |
X-xxxxxxxxxx-2-(1X-xxxxx-3-xx)xxxxxxxx |
|||
|
XXX-XXX-19 |
X-[(X)-[1-(xxxxxxxxxxxxxxxx)-2-xxx-xxxxxxx-3-xxxxxx]xxxxx]xxxxxxxx |
|||
|
XXX-XXXX-XXXXXXXX |
xxxxxxxxxxxxxxxx 2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
|
XX-XXXXX |
X-xxxxxxxxxx-2-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
|||
|
XXXX-5Xx-XXXXX |
xxxxxx 2-(5-xxxx-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
|
XXXX-7Xx-XXXXX |
xxxxxx 2-(7-xxxx-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
|
XXXX-XXXXXX |
xxxxxx 2-(1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
|
XXXX-XXXXXXXX |
xxxxxx 2-[1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx xxxxx]-3,3-xxxxxxxxxxxxxxxx |
|||
|
XXXX-XXXXX |
xxxxxx 2-(1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
|
XXXXXX |
1-xxxxxx 4-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-xxxxxxx |
|||
|
XXX-3 |
X-({2-[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-1,3-xxxxxxx-4-xx}xxxxxx)-2-xxxxxxx-X-xxxxxxxxxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxxx látek, xx na xxxxxxxx xxxxxxx, uvedených x xxxxx seznamu xx xxxxx xxxxxxxxx, kdy xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx podle xxxxxxxxxx xxxxxxxxxx xxxxxxxx a xxxx x esterů xxxxxxxxxxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx xx všech případech, xxx mohou xxxxxxxxx.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 11/2025 Xx. nabyl xxxxxxxxx xxxx 17.1.2025.
Xx xxxxx tohoto xxxxxxxx xxxxxxxx xxxx podchyceny xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
534/2025 Xx.,&xxxx;xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, x xxxxxxxx xxxxx x. 11/2025 Xx., x xxxxxxx xxxxxxxxxx psychoaktivních xxxxx
x xxxxxxxxx xx 16.12.2025
50/2026 Xx.,&xxxx;xxxxxx xx xxxx xxxxxxxx vlády x. 458/2013 Xx., x xxxxxxx výchozích x xxxxxxxxx xxxxx x xxxxxx ročních xxxxxxxxxxxx xxxxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxxx vlády č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx pozdějších xxxxxxxx, a xxxxxxxx xxxxx x. 11/2025 Xx., o xxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxx, xx xxxxx nařízení xxxxx x. 534/2025 Xx.
x xxxxxxxxx xx 3.4.2026
107/2026 Sb., kterým xx xxxx xxxxxxxx vlády x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve znění xxxxxxxxxx xxxxxxxx, x xxxxxxxx xxxxx x. 11/2025 Xx., x xxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxx, ve znění xxxxxxxxxx xxxxxxxx
x účinností xx 25.6.2026
Znění jednotlivých xxxxxxxx norem jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich xxxxxx derogační změna xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.